World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
71
Citations
22687
World Ranking
6552
National Ranking
159

Overview

David R. Booth is affiliated with the University of Sydney in Australia. Their research spans multiple disciplines primarily within Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology.

The scientist's recent publications include the following works:

  • HBV vaccination and HBV infection induces HBV-specific natural killer cell memory (2020, Gut)
  • The interaction of Multiple Sclerosis risk loci with Epstein-Barr virus phenotypes implicates the virus in pathogenesis (2020, Scientific Reports)
  • The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype (2021, EBioMedicine)
  • The Interaction of Human and Epstein-Barr Virus miRNAs with Multiple Sclerosis Risk Loci (2021, International Journal of Molecular Sciences)
  • Genetic mapping across autoimmune diseases reveals shared associations and mechanisms (2024, Nature Genetics)

The main topics covered by their research include:

  • Epigenetics and DNA Methylation
  • Viral-associated cancers and disorders
  • T-cell and B-cell Immunology
  • Systemic Lupus Erythematosus Research
  • Cardiovascular Issues in Pregnancy
  • Immune Cell Function and Interaction
  • Polyomavirus and related diseases

Their subfields of study encompass:

  • Immunology
  • Molecular Biology
  • Oncology
  • Cardiology and Cardiovascular Medicine
  • Plant Science

Frequent publication venues for their work are:

  • Scientific Reports
  • Frontiers in Immunology
  • Genes and Immunity
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Genetics

David R. Booth collaborates regularly with several co-authors, including:

  • Grant P. Parnell
  • Stephen D. Schibeci
  • Nicole Fewings
  • Lawrence T. C. Ong
  • Ali Afrasiabi

Best Publications

  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

    Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer

  • IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

    Vijayaprakash Suppiah;Max Moldovan;Golo Ahlenstiel;Thomas Berg

  • Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

    Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis

  • Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis

    David R. Booth;Margaret Sunde;Vittorio Bellotti;Vittorio Bellotti;Carol V. Robinson

  • Human lysozyme gene mutations cause hereditary systemic amyloidosis

    M. B. Pepys;P. N. Hawkins;D. R. Booth;D. M. Vigushin

  • Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.

    Helen J Lachmann;David R Booth;Susanne E Booth;Alison Bybee

  • Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20

    Melanie Bahlo;David R Booth;Simon A Broadley;Matthew A Brown;Matthew A Brown

  • Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis.

    Ebun Aganna;Fabio Martinon;Philip N. Hawkins;John B. Ross

  • Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations

    H. J. Lachmann;B. Şengül;T. U. Yavuzşen;D. R. Booth

  • Class II HLA interactions modulate genetic risk for multiple sclerosis

    L Moutsianas;L Jostins;A H Beecham;A T Dilthey

  • A high-density screen for linkage in multiple sclerosis.

    Sawcer S;Ban M;Maranian M;Yeo Tw

  • MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood

    Mathew B. Cox;Murray J. Cairns;Kaushal S. Gandhi;Adam P. Carroll

  • Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever.

    Isabelle Touitou;Tamara Sarkisian;Myrna Medlej‐Hashim;Mehmet Tunca

  • Amyloid P component. A critical review

    M B. Pepys;D. R. Booth;W. L. Hutchinson;J. R. Gallimore

  • Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.

    Jason Grebely;Kathy Petoumenos;Margaret Hellard;Margaret Hellard;Gail V. Matthews;Gail V. Matthews

  • The role of the CD58 locus in multiple sclerosis

    Philip L. De Jager;Clare Baecher-Allan;Lisa M. Maier;Ariel T. Arthur

  • Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis

    Sudarshini Ramanathan;Stephen W. Reddel;Andrew Henderson;John D.E. Parratt

  • The genetic basis of autosomal dominant familial Mediterranean fever.

    D R Booth;J D Gillmore;H J Lachmann;S E Booth

  • Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection

    Etienne Patin;Etienne Patin;Zoltán Kutalik;Zoltán Kutalik;Julien Guergnon;Stéphanie Bibert

  • Hepatitis C pharmacogenetics: State of the art in 2010†‡§

    Nezam H. Afdhal;John G. McHutchison;Stefan Zeuzem;Alessandra Mangia

Frequent Co-Authors

Graeme J. Stewart
Graeme J. Stewart University of Sydney
Jacob George
Jacob George University of Sydney
Stephen Sawcer
Stephen Sawcer University of Cambridge
David A. Hafler
David A. Hafler Yale University
Stephen L. Hauser
Stephen L. Hauser University of California, San Francisco
Jorge R. Oksenberg
Jorge R. Oksenberg University of California, San Francisco
An Goris
An Goris KU Leuven
Jan Hillert
Jan Hillert Karolinska Institute
Hanne F. Harbo
Hanne F. Harbo Oslo University Hospital
Lisa F. Barcellos
Lisa F. Barcellos University of California, Berkeley

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens doors to a variety of specialized online degrees and rewarding career pathways. For example, students interested in patient care can pursue an online asn degree to become a registered nurse. This pathway combines foundational sciences with practical clinical knowledge.

If you’re more interested in the science of nutrition and health, consider earning a nutritionist degree online. This degree blends biology with nutrition, preparing graduates to work in clinical, community, or wellness settings.

For those aiming for leadership in healthcare, top cahme-accredited mha programs offer training in healthcare management. A background in biology or biochemistry can enhance your understanding of healthcare systems and patient needs.

Advancement to high-level clinical roles is also possible through certain dnp online no clinicals options. These flexible programs allow working professionals to further their expertise and leadership skills without traditional on-campus requirements.

No matter your interest, combining biology or biochemistry with an online degree can lead to diverse and impactful careers in the health sciences.

Best Scientists Citing David R. Booth

Trending Scientists

Recently Published Articles